Burning Rock Biotech (BNR) Total Current Liabilities (2019 - 2026)

Burning Rock Biotech (BNR) has reported Total Current Liabilities for 8 consecutive years, with $33.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Current Liabilities fell 4.23% year-over-year to $33.3 million; the TTM figure through Mar 2026 stood at $33.3 million (down 4.23% YoY), while the FY2025 annual figure was $35.3 million, down 3.2% from the prior year.
• Total Current Liabilities came in at $33.3 million for Q1 2026 at Burning Rock Biotech, down from $34.8 million in the prior quarter.
• The five-year high for Total Current Liabilities was $63.1 million in Q1 2022, with the low at $32.1 million in Q2 2025.
• Average Total Current Liabilities over 5 years is $42.2 million, with a median of $36.8 million recorded in 2024.
• Across the five-year window, Total Current Liabilities jumped 50.2% in 2022 and slumped 36.77% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $57.9 million in 2022, then plunged by 36.77% to $36.6 million in 2023, then advanced by 1.35% to $37.1 million in 2024, then fell by 6.07% to $34.8 million in 2025, then declined by 4.32% to $33.3 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $33.3 million, $34.8 million, and $33.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.